Clinical Trial Update: Optimization of Adaptive Text Messages for Cancer Survivors (OATS II) [NA]

View source ↗

Summary

This update notes the completion of the OATS II trial evaluating adaptive text messaging for cancer survivors, with results posted on 2026-01-22.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Adenocarcinoma
• Colorectal Cancer
• Rectal Adenocarcinoma

Snippet

Sponsor: University of California, San Francisco | Conditions: Colon Adenocarcinoma, Colorectal Carcinoma | NA | Status: COMPLETED | Results posted: 2026-01-22